- Home
- OUST vs TSVT Comparison
OUST vs TSVT Comparison
Compare OUST & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- TSVT
- Stock Information
- Founded
- OUST 2015
- TSVT 2021
- Country
- OUST United States
- TSVT United States
- Employees
- OUST N/A
- TSVT 425
- Industry
- OUST Industrial Machinery/Components
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- TSVT Health Care
- Exchange
- OUST Nasdaq
- TSVT Nasdaq
- Market Cap
- OUST 491.7M
- TSVT 151.7M
- IPO Year
- OUST N/A
- TSVT N/A
- Fundamental
- Price
- OUST $12.68
- TSVT $3.00
- Analyst Decision
- OUST Buy
- TSVT Buy
- Analyst Count
- OUST 6
- TSVT 6
- Target Price
- OUST $12.83
- TSVT $10.40
- AVG Volume (30 Days)
- OUST 1.9M
- TSVT 384.8K
- Earning Date
- OUST 11-07-2024
- TSVT 11-12-2024
- Dividend Yield
- OUST N/A
- TSVT N/A
- EPS Growth
- OUST N/A
- TSVT N/A
- EPS
- OUST N/A
- TSVT N/A
- Revenue
- OUST $105,453,000.00
- TSVT $45,620,000.00
- Revenue This Year
- OUST $35.92
- TSVT N/A
- Revenue Next Year
- OUST $30.97
- TSVT $36.09
- P/E Ratio
- OUST N/A
- TSVT N/A
- Revenue Growth
- OUST 51.14
- TSVT N/A
- 52 Week Low
- OUST $4.65
- TSVT $2.78
- 52 Week High
- OUST $16.88
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- OUST 63.09
- TSVT 37.59
- Support Level
- OUST $11.48
- TSVT $2.83
- Resistance Level
- OUST $13.93
- TSVT $3.22
- Average True Range (ATR)
- OUST 1.36
- TSVT 0.22
- MACD
- OUST 0.13
- TSVT 0.00
- Stochastic Oscillator
- OUST 71.99
- TSVT 20.32
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.